Fahd Khalid-Salako

Fahd Khalid-Salako

Materials Science and Nano Engineering, Sabancı University, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
Fahd Khalid-SalakoFahd Khalid-Salako
Fahd Khalid-Salako
SKSoodeh Salimi Khaligh
Soodeh Salimi Khaligh
FFFarzaneh Fathi
Farzaneh Fathi
ODOsman C. Demirci
Osman C. Demirci
NÖNazlı Öncer
Nazlı Öncer
MYMeral Yüce
Meral Yüce
The field of nanomedicine is currently in a revolutionary phase, propelled by the significant potential of nanoparticles, which offer several advantages over traditional drug delivery systems. The purpose of this paper is to aggregate contemporary knowledge of nanoparticles developed and applied in drug delivery across major disease classes. Accordingly, we offer, through a thorough search of the literature, a comprehensive overview of the prevalent nanoparticles used in drug delivery systems, covering polymeric, lipid-based, inorganic, and carbon-based nanoparticles, and discuss their advantages and limitations. This work primarily focuses on studies published in the last 5 years, aiming to provide an up-to-date assessment of the critical nanoparticles in drug delivery. Narratively, we synthesize a comprehensive overview of the state-of-the-art in nanocarrier technology, providing in-depth insights into the key nanoparticle types presented in the contemporary literature, their fundamental benefits, potential clinical applications, and limitations impeding their development and adoption. We note that there are gaps and opportunities for concerted efforts focused on developing biocompatible and biodegradable nanoparticles, establishing scalable and cost-effective manufacturing processes, and addressing regulatory challenges associated with nanoparticle-based drug delivery systems. These challenges persist despite the immense translational success of nanoparticle-based drug delivery systems and necessitate continued interdisciplinary research and cross-industry collaboration among scientists, clinicians, and regulatory bodies.

1 November 2021 in Public Health in Practice
Verified
Journal Article
Open access
AAAishat Jumoke Alaran
Aishat Jumoke Alaran
YAYusuff Adebisi
Yusuff Adebisi
ABAbubakar Badmos
Abubakar Badmos
Fahd Khalid-SalakoFahd Khalid-Salako
Fahd Khalid-Salako
SGSa’iD Khalid Gaya
Sa’iD Khalid Gaya
DLDon Eliseo Lucero-Prisno
Don Eliseo Lucero-Prisno
COVID-19 is one of the major global health threats of the 21st century, causing unprecedented humanitarian crises worldwide. Despite concerted efforts to curb the spread of the disease, the pandemic continues to strain healthcare systems globally and a safe, highly effective, and globally acceptable and equitable vaccination program, together with pre-existing precautionary measures, is essential to effectively contain the outbreak. We commented on the need to level any uneven power dynamics in COVID-19 vaccines access and distribution. The COVID-19 vaccines distribution must not allow for sovereignty which is tightly linked to historical imbalances in power and resources to result into discrimination between rich and poor countries. Poor countries must be supported in ensuring access to COVID-19 vaccines by levelling the power dynamics that perpetuate inequality and fuel inequity. We must ensure equity, fairness and transparency in COVID-19 vaccines distribution and gain public trust in COVID-19 vaccines through participatory community engagement. COVID-19 vaccines distribution and access must be equitable and not politicized.

4 June 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
Fahd Khalid-SalakoFahd Khalid-Salako
Fahd Khalid-Salako
HKHasan Kurt
Hasan Kurt
MYMeral Yüce
Meral Yüce
SPR biosensors operate on the principle of evanescent wave propagation at metal–dielectric interfaces in total internal reflection conditions, with consequent photonic energy attenuation. This plasmonic excitation occurs in specific conditions of incident light wavelength, angle, and the dielectric refractive index. This principle has been the basis for SPR-based biosensor setups wherein mass/concentration-induced changes in the refractive indices of dielectric media reflect as plasmonic resonance condition changes quantitatively reported as arbitrary response units. SPR biosensors operating on this conceptual framework have been designed to study biomolecular interactions with real-time readout and in label-free setups, providing key kinetic characterization that has been valuable in various applications. SPR biosensors often feature antibodies as target affinity probes. Notably, the operational challenges encountered with antibodies have led to the development of aptamers—oligonucleotide biomolecules rationally designed to adopt tertiary structures, enabling high affinity and specific binding to a wide range of targets. Aptamers have been extensively adopted in SPR biosensor setups with promising clinical and industrial prospects. In this paper, we explore the growing literature on SPR setups featuring aptamers, specifically providing expert commentary on the current state and future implications of these SPR aptasensors for drug discovery as well as disease diagnosis and monitoring.


20 December 2024 in Biosensors
Verified
Journal Article
Open access
PDF file
Soodeh Salimi KhalighSoodeh Salimi Khaligh
Soodeh Salimi Khaligh
Fahd Khalid-SalakoFahd Khalid-Salako
Fahd Khalid-Salako
HKHasan Kurt
Hasan Kurt
MYMeral Yüce
Meral Yüce
Vascular endothelial growth factor (VEGF) is a critical angiogenesis biomarker associated with various pathological conditions, including cancer. This study leverages pre-biotinylated FcγRI interactions with IgG1-type monoclonal antibodies to develop a sensitive VEGF detection method. Utilizing surface plasmon resonance (SPR) technology, we characterized the binding dynamics of immobilized biotinylated FcγRI to an IgG1-type antibody, Bevacizumab (AVT), through kinetic studies and investigated suitable conditions for sensor surface regeneration. Subsequently, we characterized the binding of FcγRI-captured AVT to VEGF, calculating kinetic constants and binding affinity. A calibration curve was established to analyze the VEGF quantification capacity and accuracy of the biosensor, computing the limits of blank, detection, and quantification at a 95% confidence interval. Additionally, the specificity of the biosensor for VEGF over other protein analytes was assessed. This innovative biomimetic approach enabled FcγRI-mediated site-specific AVT capture, establishing a stable and reusable platform for detecting and accurately quantifying VEGF. The results indicate the effectiveness of the plasmonic sensor platform for VEGF detection, making it suitable for research applications and, potentially, clinical diagnostics. Utilizing FcγRI-IgG1 antibody binding, this study highlights the industrial and clinical value of advanced biosensing technologies, offering insights to enhance therapeutic monitoring and improve outcomes in anti-VEGF therapies.

23 August 2021 in Journal of Phytomedicine and Therapeutics
Verified
Journal Article
Closed access
PDF file
MAMercy I. Aboh
Mercy I. Aboh
MEMarlene Ekpo
Marlene Ekpo
Fahd Khalid-SalakoFahd Khalid-Salako
Fahd Khalid-Salako
POPeters O. Oladosu
Peters O. Oladosu
Urinary tract infections (UTI) a known public health problem is common in females. The objectives of this study were to assess consumers’ knowledge on possible contamination of sanitary pads, determine the quality of some commercial brands of sanitary pads and evaluate the effect of different storage conditions on their integrity. To assess consumers’ knowledge on possible contamination of sanitary pads, determine the quality of some commercial brands of sanitary pads and evaluate the effect of different storage conditions on their integrity. A cross-sectional analysis of 500 female respondents was done by a close ended, structured, interviewer dispensed inquiry form through stratified random sampling. Ten brands of sanitary pads were stored at conditions to simulate possible storage habits of consumers and at different time intervals (0, 1, 7, 14, 21 and 28 days) samples were assessed for total bacterial count (TBC) and total fungal count (TFC) via the pour plate method. Standard methods were used to isolate and identify pathogens. Results revealed that 69.4 % of respondents stored their pads in sealed enclosures, 11.8 % were not aware of the dangers of poor storage and 51.4 % agreed that poor storage could result in microbial contamination. The results on microbial burden revealed that none of the pads were contaminated at the beginning of the study (Day 0). The presence of microorganisms (B. subtilis, S. aureus and Mucor spp) were observed after 24h of storage, especially in samples with open packages and stored in open shelves, followed closely by those unsealed in enclosed environments. These microbial growths can therefore be attributed to the storage conditions of the sanitary pads. Sanitary pads can harbour pathogenic microorganisms; there is a need to properly store them and once opened use them within 14 days to prevent environmental contamination.